Ann: Results of Meeting, page-83

Putting all speculations aside, the fact of the matter is, there is now a block of votes which is large enough to prevent the board from having full control. What's more, for an entity to want such control, it can only mean that IMU has something truly great to attract such attention. And because it is Dr. Hoos being rid of, I therefore speculate that the 20% is now owned by a Big Pharma. After all, only a Big Pharma would not like such conflict of interest with Dr Hoos being executive here and a CEO of a competitor.

And I am still of the strong belief that nothing is for free. So that so-called $4m worth of avelumab being given to IMU for free, don't believe it. More like Merck/Pfizer have now owned that 20% of IMU and this $4m is an investment in their own future company

Remember, Merck had played Paul Hopper in the past with that Viralytics take over. The share price fell and fell all the way to 60 cents before a mere $500m takeover come in. I bet the same game will be played here by Merck, once there is a sniff of success in the Her-Vaxx following trials. Heck, if the OS data from the current trial should be 'belissimo', Merck/Pfizer might act already. Especially before CF33 takes off. It is the only way to takeover cheaply before other big pharma wants in.

Buckle up guys and gals. This will be one hell of a ride. Every time the share price falls even after good news, remember the fate of Viralytics. Don't get knock off cheaply is all I can say

Please note the above is just my opinion. DYOR.